Restylane Eyelight provides targeted and precise product placement helping to improve the appearance of the tear trough by replacing volume in the periorbital hollow.

Injection into the subcutaneous fatty tissue or supraperiostal administration are recommended.

Lidocaine is added to the formulation to diminish the pain resulting from the injection during the treatment.

Composition: -

• Stabilised hyaluronic acid 20 mg/mL
• Lidocaine hydrochloride 3 mg/mL
• Phosphate buffered saline q.s. ad 1 mL

Indication: Tear Trough.

Suitable needles, 29G TW (Thin wall) are supplied with the syringe in the blister pack. As an alternative, a blunt cannula with a recommended size of 27-28G can be used

We provide Galderma (U.K.) Limited with certain information on who has purchased their products through this website for consumer service/support and safety purposes. A copy of Galderma’s Privacy Notice explaining how your data will be collected, used, and disclosed by Galderma can be found here https://tinyurl.com/galdermaprivacy

Adverse events should be reported

For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

For Ireland, suspected adverse events can be reported via HPRA Pharmacovigilance, www.hpra.ie

Adverse events should also be reported to Galderma (UK) Ltd.

E-mail: Medinfo.uk@galderma.com Tel: +44 (0) 300 3035674